drugset / Trial / NCT00526760

Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects

NCT00526760

Phase 3 Completed 80 enrolled Pfizer Maruishi Pharmaceutical · collab
NaSingle-groupOpen-labelTreatment

Summary

Evaluate efficacy and safety of dexmedetomidine long term administration in ICU patients who require more than 24 hours sedation.

Timeline

Start
2007-10
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified

Indications

No indication recorded.